Author:
Andre F.,Conforti R.,Moeder C.B.,Mauguen A.,Arnedos M.,Berrada N.,Delaloge S.,Tomasic G.,Spielmann M.,Esteva F.J.,Rimm D.L.,Michiels S.
Funder
Operation Parrain Chercheurs, Career development award American Society of Clinical Oncology
Reference30 articles.
1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists’ Collaborative Group (EBCTCG);Lancet,2005
2. Anthracycline cardiotoxicity after breast cancer treatment;Hershman;Oncology,2009
3. Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracycline-based chemotherapy: a biomarker study from two randomized trials;Conforti;Ann Oncol,2007
4. KAlbainWBarlowFO’MalleyConcurrent versus sequential chemohormonal therapy versus T alone for postmenopausal, node-positive, estrogen and/or progesterone receptor-positive breast cancer: mature outcomes and new biologic correlates on phase III intergroup trial 0100In San Antonio, Texas, Breast Cancer Symposium (Abstr 37) 2004
5. Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial;International Breast Cancer Study Group;J Natl Cancer Inst,2002
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献